Talkspace, Inc. (TALK)
USD 3.09
(-5.21%)
USD 3.09
(-5.21%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 74.38 Million USD | 23.27% |
| 2022 | 60.33 Million USD | -9.64% |
| 2021 | 66.77 Million USD | 33.98% |
| 2020 | 49.83 Million USD | 147.5% |
| 2019 | 20.13 Million USD | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q2 | 20.95 Million USD | -3.59% |
| 2024 Q1 | 21.73 Million USD | 3.62% |
| 2024 Q3 | 64.28 Million USD | 3.2% |
| 2023 Q2 | 17.81 Million USD | 6.35% |
| 2023 Q1 | 16.74 Million USD | 3.54% |
| 2023 FY | 74.38 Million USD | 23.27% |
| 2023 Q4 | 20.97 Million USD | 11.26% |
| 2023 Q3 | 18.84 Million USD | 5.82% |
| 2022 Q2 | 14.54 Million USD | -3.16% |
| 2022 Q1 | 15.02 Million USD | -5.95% |
| 2022 FY | 60.33 Million USD | -9.64% |
| 2022 Q4 | 16.17 Million USD | 10.83% |
| 2022 Q3 | 14.59 Million USD | 0.33% |
| 2021 Q1 | 17.34 Million USD | 3.67% |
| 2021 FY | 66.77 Million USD | 33.98% |
| 2021 Q4 | 15.97 Million USD | 12.69% |
| 2021 Q3 | 14.17 Million USD | -26.52% |
| 2021 Q2 | 19.28 Million USD | 11.2% |
| 2020 Q3 | 15.09 Million USD | 22.62% |
| 2020 FY | 49.83 Million USD | 147.5% |
| 2020 Q4 | 16.72 Million USD | 10.85% |
| 2020 Q2 | 12.3 Million USD | 0.0% |
| 2020 Q1 | - USD | 0.0% |
| 2019 FY | 20.13 Million USD | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Acadia Healthcare Company, Inc. | 682.6 Million USD | 89.104% |
| Addus HomeCare Corporation | 339.87 Million USD | 78.116% |
| AirSculpt Technologies, Inc. | 121.9 Million USD | 38.985% |
| Amedisys, Inc. | 457.07 Million USD | 83.727% |
| American Oncology Network, Inc. | 66.05 Million USD | -12.6% |
| Astrana Health, Inc. | 214.95 Million USD | 65.398% |
| Aveanna Healthcare Holdings Inc. | 595.43 Million USD | 87.508% |
| IMAC Holdings, Inc. | 3.84 Million USD | -1832.642% |
| biote Corp. | 127.48 Million USD | 41.655% |
| Cryo-Cell International, Inc. | 22.9 Million USD | -224.784% |
| Cross Country Healthcare, Inc. | 432.06 Million USD | 82.785% |
| COMPASS Pathways plc | -242.93 Thousand USD | 30716.865% |
| DocGo Inc. | 178.95 Million USD | 58.435% |
| The Ensign Group, Inc. | 590.75 Million USD | 87.409% |
| Healthcare Services Group, Inc. | 251.45 Million USD | 70.42% |
| InnovAge Holding Corp. | 132.06 Million USD | 43.679% |
| Assure Holdings Corp. | -2.19 Million USD | 3490.155% |
| The Joint Corp. | 107.14 Million USD | 30.583% |
| LifeStance Health Group, Inc. | 302.09 Million USD | 75.379% |
| Mobile-health Network Solutions Class A Ordinary Shares | -1.07 Million USD | 7040.731% |
| ModivCare Inc. | 446.95 Million USD | 83.358% |
| NewGenIvf Group Limited | 1.68 Million USD | -4322.682% |
| Novo Integrated Sciences, Inc. | 4.95 Million USD | -1401.803% |
| Option Care Health, Inc. | 981.22 Million USD | 92.42% |
| P3 Health Partners Inc. | 31.63 Million USD | -135.119% |
| P3 Health Partners Inc. | 31.63 Million USD | -135.119% |
| The Pennant Group, Inc. | 61.9 Million USD | -20.15% |
| Surgery Partners, Inc. | 529.4 Million USD | 85.95% |
| Syra Health Corp. Class A Common Stock | 1.41 Million USD | -5168.078% |
| Talkspace, Inc. | 74.38 Million USD | 0.0% |
| The Oncology Institute, Inc. | 59.57 Million USD | -24.855% |
| The Oncology Institute, Inc. | 59.57 Million USD | -24.855% |